dc.contributor.author |
Açıkgöz, Pınar |
|
dc.contributor.author |
Türkbeyler, İbrahim Halil |
|
dc.contributor.author |
Pehlivan, Yavuz |
|
dc.date.accessioned |
2023-02-03T11:41:18Z |
|
dc.date.available |
2023-02-03T11:41:18Z |
|
dc.date.issued |
2014 |
|
dc.identifier.issn |
2147-9720 |
|
dc.identifier.uri |
http://dspace.adiyaman.edu.tr:8080/xmlui/handle/20.500.12414/4504 |
|
dc.description.abstract |
Sjogren's syndrome (SS) is an autoimmune disease characterised by a chronic inflammatory response mainly localised to the lachrymal and salivary glands. Haematological abnormalities are common, although they rarely have clinical significance. Here, we report a patient with SS and thrombocytopenia caused by albendazole. Haematological abnormalities such as thrombocytopenia are seen in approximately 5-15% of SS patients; however, this disease is usually asymptomatic and can often be recovered to normal levels with corticosteroids. If it is not, we should keep in mind other reasons for the thrombocytopenia, such as drug use. |
tr |
dc.language.iso |
en |
tr |
dc.publisher |
Aves |
tr |
dc.subject |
Thrombocytopenia |
tr |
dc.subject |
Albendazole |
tr |
dc.subject |
Sjogren's syndrome |
tr |
dc.title |
Thrombocytopenia caused by albendazole in a patient with Sjogren's syndrome: A case report |
tr |
dc.type |
Article |
tr |
dc.contributor.department |
Gaziantep Univ,/Fac Med,/Dept Internal Med. |
tr |
dc.contributor.department |
Adiyaman Univ,/Fac Med,/Dept Internal Med. |
tr |
dc.contributor.department |
Gaziantep Univ,/Fac Med,/Dept Internal Med,/Div Rheumatol. |
tr |
dc.identifier.endpage |
45 |
tr |
dc.identifier.issue |
1 |
tr |
dc.identifier.startpage |
44 |
tr |
dc.identifier.volume |
1 |
tr |
dc.source.title |
European Journal Of Rheumatology |
tr |